跳转至内容
Merck
CN

SML1546

Sigma-Aldrich

SCR7 吡嗪

≥98% (HPLC), non-homologous end joining inhibitor, powder

别名:

2,3-二氢-6,7-二苯基-2-硫代-4 (1H)-蝶啶酮, 6,7-二苯基-2-硫代-卢马嗪 (8CI)

登录查看公司和协议定价

选择尺寸

关于此项目

经验公式（希尔记法）:
C18H12N4OS
化学文摘社编号:
14892-97-8
分子量:
332.38
MDL编号:
MFCD02167478
UNSPSC代码:
12352200
PubChem化学物质编号:
329825955
NACRES:
NA.77

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

SCR7 吡嗪, ≥98% (HPLC)

质量水平

100

方案

≥98% (HPLC)

表单

powder

颜色

faintly yellow to dark yellow

溶解性

DMSO: 10 mg/mL, clear

储存温度

room temp

SMILES字符串

O=C(C1=C(N2)N=C(C3=CC=CC=C3)C(C4=CC=CC=C4)=N1)NC2=S

InChI

1S/C18H12N4OS/c23-17-15-16(21-18(24)22-17)20-14(12-9-5-2-6-10-12)13(19-15)11-7-3-1-4-8-11/h1-10H,(H2,20,21,22,23,24)

InChI key

GSRTWXVBHGOUBU-UHFFFAOYSA-N

相关类别

一般描述

SCR7 吡嗪是 DNA 连接酶 IV 的抑制剂。

应用

SCR7 吡嗪已被用作非同源末端连接 (NHEJ) 调节剂，研究其对 CRISPR/Cas9 介导的编辑的影响。
SCR7 吡嗪已被证明可以增强 CRISPR 基因组编辑效率。要查看其他小分子 CRISPR 增强子，请访问 sigma.com/CRISPR-enhancers。

生化/生理作用

据报道，SCR7 吡嗪是非同源末端连接 (NHEJ) 的抑制剂，并已被证明可增强 CRISPR-Cas9 基因组编辑的效率。
据报道，SCR7 吡嗪是非同源末端连接 (NHEJ) 的抑制剂，并已被证明可增强 CRISPR-Cas9 基因组编辑的效率。SCR7 吡嗪对 CRISPR 应用效率和靶向精度的影响已被证明是细胞类型特异性和上下文依赖性的。sr7 吡嗪是 sr7 自发环化的产物，由 Srivastava 等人首先报道。

象形图

Exclamation mark
GHS07

警示用语：

Warning

危险声明

H302

危险分类

Acute Tox. 4 Oral

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
0000091591
0000092196
0000062535
0000043973
0000043974

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Diane Yang et al.
Scientific reports, 6, 21264-21264 (2016-02-19)
Efficient gene editing is essential to fully utilize human pluripotent stem cells (hPSCs) in regenerative medicine. Custom endonuclease-based gene targeting involves two mechanisms of DNA repair: homology directed repair (HDR) and non-homologous end joining (NHEJ). HDR is the preferred mechanism
pRB-Depleted Pluripotent Stem Cell Retinal Organoids Recapitulate Cell State Transitions of Retinoblastoma Development and Suggest an Important Role for pRB in Retinal Cell Differentiation.
Rozanska, et al.
Stem Cells Translational Medicine, 11, 415-433 (2023)
Disruption of diphthamide synthesis genes and resulting toxin resistance as a robust technology for quantifying and optimizing CRISPR/Cas9-mediated gene editing.
Killian T, et al.
Scientific Reports, 7(1), 15480-15480 (2017)
Yuanwu Ma et al.
RNA biology, 13(7), 605-612 (2016-05-11)
Precise modifications such as site mutation, codon replacement, insertion or precise targeted deletion are needed for studies of accurate gene function. The CRISPR/Cas9 system has been proved as a powerful tool to generate gene knockout and knockin animals. But the
Justin Moser et al.
Proceedings of the National Academy of Sciences of the United States of America, 115(35), E8219-E8227 (2018-08-17)
The Restriction Point was originally defined as the moment that cells commit to the cell cycle and was later suggested to coincide with hyperphosphorylation of the retinoblastoma protein (Rb). Current cell cycle models posit that cells exit mitosis into a
查看所有相关文献

商品

CRISPR小分子增强剂

业内研究了CRISPR基因组编辑背景下的HDR调控，发现各种细胞类型中增强CRISPR介导的HDR效率的小分子。

Small Molecule CRISPR Enhancers

Modulation of homology-directed repair (HDR) within the context of CRISPR-genome editing has led to the identification of small molecules that enhance CRISPR-mediated HDR efficiency in various cell types.

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持